A non-interventional, post authorisation safety study to continously monitor safety and pregnancy outcomes in a cohort of at-risk ET subjects exposed to Xagrid compared to other conventional cytoreductive therapies (EXELS)
A long-term observational study assessing the safety of anagrelide (Xagrid) in ET patients, comparing outcomes with hydroxycarbamide-treated patients over 10 years. Inclusion closed in 2009; follow-up ongoing.
A Phase II Study of Vorinostat in Patients with Polycythaemia Vera and Essential Thrombocythaemia. EudraCT # 2007-005306-49
A Danish retrospective study investigating JAK2 allele burden in PV, ET, and PMF patients before and after interferon therapy, aiming to validate blood and bone marrow correlation.
Alpha-Interferon therapy of Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
A Danish retrospective study investigating JAK2 allele burden in PV, ET, and PMF patients before and after interferon therapy, aiming to validate blood and bone marrow correlation.
Prospective study of Quality-of-Life in newly diagnosed MPN patients
A Swedish study led by Peter Johansson assessing quality of life in MPN patients from diagnosis through three years, using EORTC QLQ-C30 and MPN-SAF tools.
